# JUN

## Overview
The JUN gene encodes the Jun proto-oncogene, AP-1 transcription factor subunit, a pivotal component of the AP-1 transcription factor complex. This protein is categorized as a transcription factor due to its role in regulating gene expression in response to various extracellular stimuli. The JUN protein is characterized by a basic leucine zipper (bZIP) domain, which facilitates dimerization and DNA binding, allowing it to form heterodimers with other bZIP proteins such as FOS. These interactions enable JUN to modulate the transcription of target genes involved in critical cellular processes, including proliferation, differentiation, and apoptosis (Panne2004Crystal; Glover1995Crystal). The activity of the JUN protein is regulated by post-translational modifications, such as phosphorylation, which influence its transcriptional activity and DNA binding ability, thereby playing a significant role in cell cycle progression and stress responses (Shaulian2002AP-1). The dysregulation of JUN has been implicated in various pathological conditions, including cancer and inflammatory diseases, highlighting its clinical significance (Zenz2005Psoriasislike; Chen2022Bioinformatic).

## Structure
The JUN protein, encoded by the JUN gene, is a component of the AP-1 transcription factor complex and is characterized by a basic leucine zipper (bZIP) domain. This domain facilitates dimerization and DNA binding, allowing JUN to form heterodimers with other bZIP proteins such as FOS (Panne2004Crystal; Glover1995Crystal). The JUN protein structure includes continuous alpha-helices that form a coiled-coil dimerization interface, particularly at the C-terminal leucine zipper region (Panne2004Crystal). The N-terminal basic regions of JUN interact with the major groove of DNA, contributing to its DNA-binding specificity (Panne2004Crystal).

The JUN protein is involved in forming heterodimers that bind DNA in a specific orientation, with the ability to recognize the AP-1 site in multiple orientations (Glover1995Crystal). The structure of JUN, when bound to DNA, shows flexibility, allowing it to adapt to different DNA conformations and partner proteins (Chen1998Structure). Post-translational modifications, such as phosphorylation, can influence the activity of JUN, although specific modifications are not detailed in the provided context. The structural integrity and function of JUN are crucial for its role in regulating gene expression in response to various stimuli.

## Function
The JUN gene encodes the c-Jun protein, a critical component of the AP-1 transcription factor complex, which regulates gene expression in response to various stimuli, including growth factors, cytokines, and stress. In healthy human cells, c-Jun plays a significant role in cell proliferation, differentiation, and apoptosis. It functions by forming dimers with other proteins, such as those from the Fos family, to bind specific DNA sequences known as AP-1 sites, thereby modulating the transcription of target genes (Vogt1989The).

c-Jun is essential for cell cycle progression, particularly the transition from the G1 to S phase. It achieves this by inducing the transcription of cyclin D1, a key regulator of the cell cycle, and repressing the expression of the tumor suppressor p53 and its target gene p21, which are involved in growth inhibition (Shaulian2002AP-1; Schreiber1999Control). The protein is also involved in cellular responses to UV-induced stress, where it helps protect cells from apoptosis by modulating p53 activity (Wisdom1999cJun).

c-Jun's activity is regulated by phosphorylation, particularly through the JNK signaling pathway, which enhances its transcriptional activity and DNA binding ability, contributing to its role in cell proliferation and survival (Shaulian2002AP-1).

## Clinical Significance
Mutations and alterations in the JUN gene, which encodes a component of the AP-1 transcription factor complex, have been implicated in various diseases. In psoriasis, a chronic inflammatory skin condition, the downregulation of JunB, a component of AP-1, is critical. In mouse models, the deletion of both JunB and c-Jun leads to psoriasis-like skin lesions and arthritis, suggesting that these proteins play a significant role in the disease's pathogenesis (Zenz2005Psoriasislike). 

In cervical cancer, upregulated expression of the JUN gene has been associated with poor prognosis. This upregulation is linked to mutations induced by APOBEC enzymes, particularly in the FLG gene, highlighting JUN's role in cancer progression (Chen2022Bioinformatic). 

JUN is also involved in stress-induced apoptosis and cellular proliferation. Alterations in its N-terminal phosphorylation can affect cellular responses to stress, potentially contributing to conditions like epilepsy and neurodegenerative diseases (Behrens1999Aminoterminal). In respiratory diseases, JUN, through its interaction with JNK, plays a role in apoptosis regulation, which is significant in conditions such as idiopathic pulmonary fibrosis (Bennett2006cJun).

## Interactions
The JUN protein, a component of the AP-1 transcription factor complex, engages in various protein-protein and protein-DNA interactions. JUN forms heterodimers with FOS proteins, which are more stable than JUN homodimers. This stability is attributed to the leucine zipper motif, which facilitates dimerization and enhances DNA binding affinity (Smeal1989Different). JUN also interacts with JDP1 and JDP2 proteins. JDP1 forms a binding complex with JUN, while JDP2 can independently bind to the jun-TRE DNA element and enhance JUN's binding, indicating regulatory interactions (Aronheim1997Isolation).

JUN's interaction with the glucocorticoid receptor (GCR) involves mutual inhibition of DNA binding, mediated by the leucine zipper region. This interaction does not involve direct DNA binding but suggests a protein-protein interaction mechanism (YangYen1990Transcriptional). In the context of quercetin treatment in prostate cancer cells, JUN interacts with Sp1 and the androgen receptor (AR), forming complexes that repress AR transcriptional activity (Yuan2010Suppression).

JUN is also part of the AP-1 complex, which includes dimers of Jun, Fos, and ATF proteins. These dimers bind to AP-1 sites, influencing gene regulation in response to extracellular stimuli (Aronheim1997Isolation).


## References


[1. (Wisdom1999cJun) R. Wisdom. C-jun regulates cell cycle progression and apoptosis by distinct mechanisms. The EMBO Journal, 18(1):188–197, January 1999. URL: http://dx.doi.org/10.1093/emboj/18.1.188, doi:10.1093/emboj/18.1.188. This article has 527 citations.](https://doi.org/10.1093/emboj/18.1.188)

[2. (YangYen1990Transcriptional) Hsin-Fang Yang-Yen, Jean-Claude Chambard, Yu-Lin Sun, Tod Smeal, Thomas J. Schmidt, Jacques Drouin, and Michael Karin. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of dna binding due to direct protein-protein interaction. Cell, 62(6):1205–1215, September 1990. URL: http://dx.doi.org/10.1016/0092-8674(90)90396-v, doi:10.1016/0092-8674(90)90396-v. This article has 1125 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(90)90396-v)

[3. (Yuan2010Suppression) Huiqing Yuan, Charles Y. F. Young, Yuanyuan Tian, Zhifang Liu, Mengye Zhang, and Hongxiang Lou. Suppression of the androgen receptor function by quercetin through protein–protein interactions of sp1, c-jun, and the androgen receptor in human prostate cancer cells. Molecular and Cellular Biochemistry, 339(1–2):253–262, February 2010. URL: http://dx.doi.org/10.1007/s11010-010-0388-7, doi:10.1007/s11010-010-0388-7. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-010-0388-7)

[4. (Behrens1999Aminoterminal) Axel Behrens, Maria Sibilia, and Erwin F. Wagner. Amino-terminal phosphorylation of c-jun regulates stress-induced apoptosis and cellular proliferation. Nature Genetics, 21(3):326–329, March 1999. URL: http://dx.doi.org/10.1038/6854, doi:10.1038/6854. This article has 563 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/6854)

[5. (Aronheim1997Isolation) Ami Aronheim, Ebrahim Zandi, Hanjo Hennemann, Stephen J. Elledge, and Michael Karin. Isolation of an ap-1 repressor by a novel method for detecting protein-protein interactions. Molecular and Cellular Biology, 17(6):3094–3102, June 1997. URL: http://dx.doi.org/10.1128/mcb.17.6.3094, doi:10.1128/mcb.17.6.3094. This article has 374 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.6.3094)

[6. (Vogt1989The) Peter K. Vogt and Timothy J. Bos. The oncogene jun and nuclear signalling. Trends in Biochemical Sciences, 14(5):172–175, May 1989. URL: http://dx.doi.org/10.1016/0968-0004(89)90268-5, doi:10.1016/0968-0004(89)90268-5. This article has 73 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/0968-0004(89)90268-5)

[7. (Schreiber1999Control) M. Schreiber, A. Kolbus, F. Piu, A. Szabowski, U. Mohle-Steinlein, J. Tian, M. Karin, P. Angel, and E. F. Wagner. Control of cell cycle progression by c-jun is p53 dependent. Genes &amp; Development, 13(5):607–619, March 1999. URL: http://dx.doi.org/10.1101/gad.13.5.607, doi:10.1101/gad.13.5.607. This article has 452 citations.](https://doi.org/10.1101/gad.13.5.607)

[8. (Chen1998Structure) Lin Chen, J. N. Mark Glover, Patrick G. Hogan, Anjana Rao, and Stephen C. Harrison. Structure of the dna-binding domains from nfat, fos and jun bound specifically to dna. Nature, 392(6671):42–48, March 1998. URL: http://dx.doi.org/10.1038/32100, doi:10.1038/32100. This article has 411 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/32100)

[9. (Smeal1989Different) T Smeal, P Angel, J Meek, and M Karin. Different requirements for formation of jun: jun and jun: fos complexes. Genes &amp; Development, 3(12b):2091–2100, December 1989. URL: http://dx.doi.org/10.1101/gad.3.12b.2091, doi:10.1101/gad.3.12b.2091. This article has 182 citations.](https://doi.org/10.1101/gad.3.12b.2091)

[10. (Bennett2006cJun) B. L. Bennett. C-jun n-terminal kinase-dependent mechanisms in respiratory disease. European Respiratory Journal, 28(3):651–661, August 2006. URL: http://dx.doi.org/10.1183/09031936.06.00012106, doi:10.1183/09031936.06.00012106. This article has 44 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1183/09031936.06.00012106)

[11. (Panne2004Crystal) Daniel Panne, Tom Maniatis, and Stephen C Harrison. Crystal structure of atf-2/c-jun and irf-3 bound to the interferon-β enhancer. The EMBO Journal, 23(22):4384–4393, October 2004. URL: http://dx.doi.org/10.1038/sj.emboj.7600453, doi:10.1038/sj.emboj.7600453. This article has 144 citations.](https://doi.org/10.1038/sj.emboj.7600453)

[12. (Zenz2005Psoriasislike) Rainer Zenz, Robert Eferl, Lukas Kenner, Lore Florin, Lars Hummerich, Denis Mehic, Harald Scheuch, Peter Angel, Erwin Tschachler, and Erwin F. Wagner. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of jun proteins. Nature, 437(7057):369–375, September 2005. URL: http://dx.doi.org/10.1038/nature03963, doi:10.1038/nature03963. This article has 462 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature03963)

[13. (Chen2022Bioinformatic) Huan Chen, Liyun Zhao, Jiaqiang Liu, Housheng Zhou, Xi Wang, Xiaoling Fang, and Xiaomeng Xia. Bioinformatic analyzes of the association between upregulated expression of jun gene via apobec-induced flg gene mutation and prognosis of cervical cancer. Frontiers in Medicine, April 2022. URL: http://dx.doi.org/10.3389/fmed.2022.815450, doi:10.3389/fmed.2022.815450. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmed.2022.815450)

[14. (Glover1995Crystal) J. N. Mark Glover and Stephen C. Harrison. Crystal structure of the heterodimeric bzip transcription factor c-fos–c-jun bound to dna. Nature, 373(6511):257–261, January 1995. URL: http://dx.doi.org/10.1038/373257a0, doi:10.1038/373257a0. This article has 589 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/373257a0)

[15. (Shaulian2002AP-1) Eitan Shaulian and Michael Karin. Ap-1 as a regulator of cell life and death. Nature Cell Biology, 4(5):E131–E136, May 2002. URL: http://dx.doi.org/10.1038/ncb0502-e131, doi:10.1038/ncb0502-e131. This article has 2241 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncb0502-e131)